Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer
A multicenter Open-label, single-arm feasibility study is conducted on patients with
histological stage IV colorectal cancer given oxaliplatin, leucovorin plus fluorouracil. The
usefulness of this regimens as therapy for colorectal cancer was evaluated by the
disease-free survival rate (DFR), overall survival rate (OS), incidence and severity of
adverse event.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Incidence and severity of adverse event
Masahiro Asaka, MD, PhD
Study Chair
Hokkaido Gastrointestinal Cancer Study Group
Japan: Ministry of Health, Labor and Welfare
HGCSG0501
NCT00209703
January 2005
June 2007
Name | Location |
---|